Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst during Respiratory Fungal Challenge

Journal of Infectious Diseases

Volumn 213, Issue 8, 2016, Pages 1289-1298

  Kasahara, Shinji ^a   Jhingran, Anupam ^a   Dhingra, Sourabh ^c   Salem, Anand ^a   Cramer, Robert A ^c   Hohl, Tobias M ^a,b  

^a Infectious Disease Service   (Georgia)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Aspergillus; GM CSF; monocytes; neutrophils; ROS

Indexed keywords

CD131 ANTIGEN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ANTIFUNGAL AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; ENZYME ACTIVITY; FUNGUS GROWTH; FUNGUS HYPHAE; IN VIVO STUDY; LEUKOCYTE; LUNG CLEARANCE; LUNG LAVAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY TRACT INFECTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; ANIMAL; ASPERGILLOSIS; CELL CULTURE; FLOW CYTOMETRY; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METABOLISM; RESPIRATORY BURST;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELLS, CULTURED; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MONOCYTES; NEUTROPHIL ACTIVATION; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

EID: 84965117748     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw054     Document Type: Article

References (50)

1. Segal BH. Aspergillosis. N Engl J Med 2009; 360:1870-84.
2. Bonnett CR, Cornish EJ, Harmsen AG, Burritt JB. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect Immun 2006; 74:6528-39.
3. Espinosa V, Jhingran A, Dutta O, et al. Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog 2014; 10:e1003940.
4. Mircescu MM, Lipuma L, van Rooijen N, Pamer EG, Hohl TM. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J Infect Dis 2009; 200:647-56.
5. Cordonnier C, Ribaud P, Herbrecht R, et al. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: A 1-year retrospective study of consecutive patients at French transplantation centers. Clin Infect Dis 2006; 42:955-63.
6. Punatar AD, Kusne S, Blair JE, Seville MT, Vikram HR. Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infect 2012; 65:173-9.
7. Burgess AW, Camakaris J, Metcalf D. Purification and properties of colonystimulating factor from mouse lung-conditioned medium. J Biol Chem 1977; 252:1998-2003.
8. Metcalf D. Hematopoietic cytokines. Blood 2008; 111:485-91.
9. Fleetwood AJ, Cook AD, Hamilton JA. Functions of granulocyte-macrophage colony-stimulating factor. Crit Rev Immunol 2005; 25:405-28.
10. Gonzalez-Juarrero M, Hattle JM, Izzo A, et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol 2005; 77:914-22.
11. Ballinger MN, Paine R III, Serezani CH, et al. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 2006; 34:766-74.
12. Paine R III, Preston AM,Wilcoxen S, et al. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol 2000; 164:2602-9.
13. Riopel J, Tam M, Mohan K, Marino MW, Stevenson MM. Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria. Infect Immun 2001; 69:129-36.
14. Weisbart RH, Kwan L, Golde DW, Gasson JC. Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 1987; 69:18-21.
15. Lopez AF, Nicola NA, Burgess AW, et al. Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol 1983; 131:2983-8.
16. Whitney PG, Bar E, Osorio F, et al. Syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection. PLoS Pathog 2014; 10:e1004276.
17. Subramanian Vignesh K, Landero Figueroa JA, Porollo A, Caruso JA, Deepe GS Jr. Granulocyte macrophage-colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. Immunity 2013; 39:697-710.
18. Deepe GS Jr, Gibbons R,Woodward E. Neutralization of endogenous granulocytemacrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J Immunol 1999; 163:4985-93.
19. Tanaka T, Motoi N, Tsuchihashi Y, et al. Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB. J Med Genet 2011; 48:205-9.
20. Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC. GMCSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001; 15:557-67.
21. Tazawa R, Inoue Y, Arai T, et al. Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colonystimulating factor therapy. Chest 2014; 145:729-37.
22. Shepardson KM, Jhingran A, Caffrey A, et al. Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection. PLoS Pathog 2014; 10:e1004378.
23. Jhingran A, Mar KB, Kumasaka DK, et al. Tracing conidial fate and measuring host cell antifungal activity using a reporter of microbial viability in the lung. Cell Rep 2012; 2:1762-73.
24. Hohl TM, Rivera A, Lipuma L, et al. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 2009; 6:470-81.
25. Mehrad B, Strieter RM, Standiford TJ. Role of TNF-α in pulmonary host defense in murine invasive aspergillosis. J Immunol 1999; 162:1633-40.
26. Mehrad B, Strieter RM, Moore TA, Tsai WC, Lira SA, Standiford TJ. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol 1999; 163:6086-94.
27. Jhingran A, Kasahara S, Shepardson KM, et al. Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection. PLoS Pathog 2015; 11:e1004589.
28. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A 1994; 91:5592-6.
29. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocytemacrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264:713-6.
30. Antman KS, Griffin JD, Elias A, et al. Effect of recombinant human granulocytemacrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 1988; 319:593-8.
31. Tazawa R, Hamano E, Arai T, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005; 171:1142-9.
32. Wirnsberger G, Zwolanek F, Stadlmann J, et al. Jagunal homolog 1 is a critical regulator of neutrophil function in fungal host defense. Nat Genet 2014; 46:1028-33.
33. Gavino C, Cotter A, Lichtenstein D, et al. CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy. Clin Infect Dis 2014; 59:81-4.
34. Bandera A, Trabattoni D, Ferrario G, et al. Interferon-γ and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis. Infection 2008; 36:368-73.
35. Abu Jawdeh L, Haidar R, Bitar F, et al. Aspergillus vertebral osteomyelitis in a child with a primary monocyte killing defect: response to GM-CSF therapy. J Infect 2000; 41:97-100.
36. Quezada G, Koshkina NV, Zweidler-McKay P, Zhou Z, Kontoyiannis DP, Kleinerman ES. Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Antimicrob Agents Chemother 2008; 52:716-8.
37. Brummer E, Kamberi M, Stevens DA. Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia. J Infect Dis 2003; 187:705-9.
38. Roilides E, Holmes A, Blake C, Venzon D, Pizzo PA,Walsh TJ. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J Infect Dis 1994; 170:894-9.
39. El-Benna J, Dang PM, Gougerot-Pocidalo MA. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol 2008; 30:279-89.
40. Croxford AL, Lanzinger M, Hartmann FJ, et al. the cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity 2015; 43:502-14.
41. Yao Y, Matsushima H, Ohtola JA, Geng S, Lu R, Takashima A. Neutrophil priming occurs in a sequential manner and can be visualized in living animals by monitoring IL-1β promoter activation. J Immunol 2015; 194:1211-24.
42. Taylor PR, Roy S, Leal SM Jr, et al. Activation of neutrophils by autocrine IL-17AIL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. Nat Immunol 2014; 15:143-51.
43. Churchill L, Friedman B, Schleimer RP, Proud D. Production of granulocytemacrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology 1992; 75:189-95.
44. Blau H, Riklis S, Kravtsov V, Kalina M. Secretion of cytokines by rat alveolar epithelial cells: possible regulatory role for SP-A. Am J Physiol 1994; 266:L148-55.
45. Morrison BE, Park SJ, Mooney JM, Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 2003; 112:1862-70.
46. Park SJ, Hughes MA, Burdick M, Strieter RM, Mehrad B. Early NK cell-derived IFN-γ is essential to host defense in neutropenic invasive aspergillosis. J Immunol 2009; 182:4306-12.
47. Mortha A, Chudnovskiy A, Hashimoto D, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 2014; 343:1249288.
48. Marr KA, Schlamm HT, Herbrecht R, et al. Combination antifungal therapy for invasive aspergillosis: A randomized trial. Ann Intern Med 2015; 162:81-9.
49. Wan L, Zhang Y, Lai Y, et al. Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: A prospective multicenter randomized phase IV trial. J Clin Oncol 2015; 33:3999-4006.
50. van der Linden JW, Camps SM, Kampinga GA, et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 2013; 57:513-20.